Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Immunomedics Dodges Manufacturing Site Specifics In Quest For Cancer Breakthrough Approval

Discretion

Related Content

Pharmacia & Upjohn Camptosar sales are $41.2 mil. in first quarter.

May 05 1997

The Next New Thing In FDA Inspections: Poor Root Cause Investigations

Jan 07 2019

Keeping Track: FDA's Review Actions Carry On During Shutdown

Jan 20 2019

Related Companies

Immunomedics, Inc.

Samsung Bioepis Co., Ltd.

Johnson Matthey Plc

Pfizer Inc.

Additional Topics

United States Quality Manufacturing Complete Response Letters Compliance Biologics Cancer BioPharmaceutical

More from Manufacturing

More from Compliance

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window